nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1B—hypertension	0.269	1	CbGaD
Frovatriptan—HTR1B—Pindolol—hypertension	0.0585	0.133	CbGbCtD
Frovatriptan—HTR1B—Penbutolol—hypertension	0.0477	0.109	CbGbCtD
Frovatriptan—HTR1A—Nebivolol—hypertension	0.0431	0.098	CbGbCtD
Frovatriptan—HTR1D—Prazosin—hypertension	0.0393	0.0895	CbGbCtD
Frovatriptan—HTR1A—Pindolol—hypertension	0.0367	0.0834	CbGbCtD
Frovatriptan—HTR1B—Propranolol—hypertension	0.03	0.0681	CbGbCtD
Frovatriptan—HTR1A—Penbutolol—hypertension	0.0299	0.068	CbGbCtD
Frovatriptan—HTR1A—Prazosin—hypertension	0.0236	0.0537	CbGbCtD
Frovatriptan—HTR1A—Propranolol—hypertension	0.0188	0.0427	CbGbCtD
Frovatriptan—CYP1A2—Triamterene—hypertension	0.0152	0.0346	CbGbCtD
Frovatriptan—CYP1A2—Guanabenz—hypertension	0.0152	0.0346	CbGbCtD
Frovatriptan—CYP1A2—Betaxolol—hypertension	0.0126	0.0287	CbGbCtD
Frovatriptan—CYP1A2—Nisoldipine—hypertension	0.0111	0.0253	CbGbCtD
Frovatriptan—CYP1A2—Irbesartan—hypertension	0.00875	0.0199	CbGbCtD
Frovatriptan—CYP1A2—Amlodipine—hypertension	0.00858	0.0195	CbGbCtD
Frovatriptan—CYP1A2—Nifedipine—hypertension	0.008	0.0182	CbGbCtD
Frovatriptan—CYP1A2—Carvedilol—hypertension	0.00787	0.0179	CbGbCtD
Frovatriptan—CYP1A2—Propranolol—hypertension	0.00725	0.0165	CbGbCtD
Frovatriptan—CYP1A2—Clonidine—hypertension	0.00691	0.0157	CbGbCtD
Frovatriptan—CYP1A2—Losartan—hypertension	0.00564	0.0128	CbGbCtD
Frovatriptan—CYP1A2—Verapamil—hypertension	0.00497	0.0113	CbGbCtD
Frovatriptan—HTR1B—artery—hypertension	0.000941	0.121	CbGeAlD
Frovatriptan—HTR1D—artery—hypertension	0.000911	0.117	CbGeAlD
Frovatriptan—CYP1A2—urine—hypertension	0.000832	0.107	CbGeAlD
Frovatriptan—HTR1B—blood vessel—hypertension	0.000733	0.0943	CbGeAlD
Frovatriptan—HTR1D—blood vessel—hypertension	0.00071	0.0913	CbGeAlD
Frovatriptan—HTR1B—brainstem—hypertension	0.000401	0.0516	CbGeAlD
Frovatriptan—HTR1D—brainstem—hypertension	0.000388	0.0499	CbGeAlD
Frovatriptan—HTR1B—cardiovascular system—hypertension	0.000327	0.0421	CbGeAlD
Frovatriptan—HTR1A—brainstem—hypertension	0.000323	0.0416	CbGeAlD
Frovatriptan—HTR1D—cardiovascular system—hypertension	0.000317	0.0407	CbGeAlD
Frovatriptan—HTR1D—kidney—hypertension	0.00031	0.0399	CbGeAlD
Frovatriptan—HTR1A—cardiovascular system—hypertension	0.000264	0.034	CbGeAlD
Frovatriptan—HTR1B—endocrine gland—hypertension	0.000224	0.0289	CbGeAlD
Frovatriptan—HTR1A—adrenal gland—hypertension	0.000209	0.0269	CbGeAlD
Frovatriptan—HTR1B—central nervous system—hypertension	0.000202	0.026	CbGeAlD
Frovatriptan—HTR1D—central nervous system—hypertension	0.000196	0.0252	CbGeAlD
Frovatriptan—HTR1A—endocrine gland—hypertension	0.000181	0.0233	CbGeAlD
Frovatriptan—HTR1A—central nervous system—hypertension	0.000163	0.021	CbGeAlD
Frovatriptan—CYP1A2—endocrine gland—hypertension	0.000138	0.0178	CbGeAlD
Frovatriptan—Feeling abnormal—Perindopril—hypertension	2.55e-05	0.000129	CcSEcCtD
Frovatriptan—Dizziness—Verapamil—hypertension	2.55e-05	0.000129	CcSEcCtD
Frovatriptan—Pain—Betaxolol—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Constipation—Betaxolol—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Feeling abnormal—Irbesartan—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Headache—Indapamide—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Headache—Diltiazem—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Pruritus—Valsartan—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Dry mouth—Ramipril—hypertension	2.54e-05	0.000128	CcSEcCtD
Frovatriptan—Chest pain—Timolol—hypertension	2.53e-05	0.000128	CcSEcCtD
Frovatriptan—Arthralgia—Timolol—hypertension	2.53e-05	0.000128	CcSEcCtD
Frovatriptan—Myalgia—Timolol—hypertension	2.53e-05	0.000128	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Perindopril—hypertension	2.53e-05	0.000128	CcSEcCtD
Frovatriptan—Anxiety—Timolol—hypertension	2.53e-05	0.000128	CcSEcCtD
Frovatriptan—Pruritus—Olmesartan—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Vomiting—Doxazosin—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Decreased appetite—Losartan—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Irbesartan—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Feeling abnormal—Hydrochlorothiazide—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Hypersensitivity—Clonidine—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Abdominal pain—Captopril—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Body temperature increased—Captopril—hypertension	2.52e-05	0.000127	CcSEcCtD
Frovatriptan—Headache—Carvedilol—hypertension	2.51e-05	0.000127	CcSEcCtD
Frovatriptan—Confusional state—Ramipril—hypertension	2.51e-05	0.000127	CcSEcCtD
Frovatriptan—Discomfort—Timolol—hypertension	2.5e-05	0.000126	CcSEcCtD
Frovatriptan—Fatigue—Losartan—hypertension	2.5e-05	0.000126	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.5e-05	0.000126	CcSEcCtD
Frovatriptan—Vomiting—Fosinopril—hypertension	2.49e-05	0.000126	CcSEcCtD
Frovatriptan—Malaise—Lisinopril—hypertension	2.49e-05	0.000126	CcSEcCtD
Frovatriptan—Nausea—Propranolol—hypertension	2.49e-05	0.000126	CcSEcCtD
Frovatriptan—Anaphylactic shock—Ramipril—hypertension	2.49e-05	0.000126	CcSEcCtD
Frovatriptan—Headache—Doxazosin—hypertension	2.49e-05	0.000126	CcSEcCtD
Frovatriptan—Vertigo—Lisinopril—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Dry mouth—Timolol—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Pain—Losartan—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Constipation—Losartan—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Syncope—Lisinopril—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Vomiting—Eplerenone—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Feeling abnormal—Furosemide—hypertension	2.48e-05	0.000125	CcSEcCtD
Frovatriptan—Vomiting—Nifedipine—hypertension	2.46e-05	0.000124	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Furosemide—hypertension	2.46e-05	0.000124	CcSEcCtD
Frovatriptan—Headache—Fosinopril—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Hypersensitivity—Trandolapril—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Diarrhoea—Valsartan—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Asthenia—Clonidine—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Feeling abnormal—Betaxolol—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Confusional state—Timolol—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Vomiting—Verapamil—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Shock—Ramipril—hypertension	2.45e-05	0.000124	CcSEcCtD
Frovatriptan—Hypersensitivity—Enalapril—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Abdominal pain—Perindopril—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Body temperature increased—Perindopril—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Palpitations—Lisinopril—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Diarrhoea—Olmesartan—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Headache—Eplerenone—hypertension	2.44e-05	0.000123	CcSEcCtD
Frovatriptan—Abdominal pain—Irbesartan—hypertension	2.43e-05	0.000123	CcSEcCtD
Frovatriptan—Body temperature increased—Irbesartan—hypertension	2.43e-05	0.000123	CcSEcCtD
Frovatriptan—Anaphylactic shock—Timolol—hypertension	2.43e-05	0.000123	CcSEcCtD
Frovatriptan—Loss of consciousness—Lisinopril—hypertension	2.43e-05	0.000123	CcSEcCtD
Frovatriptan—Tachycardia—Ramipril—hypertension	2.43e-05	0.000123	CcSEcCtD
Frovatriptan—Headache—Nifedipine—hypertension	2.42e-05	0.000122	CcSEcCtD
Frovatriptan—Pruritus—Clonidine—hypertension	2.42e-05	0.000122	CcSEcCtD
Frovatriptan—Abdominal pain—Hydrochlorothiazide—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Body temperature increased—Hydrochlorothiazide—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Headache—Verapamil—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Hypersensitivity—Telmisartan—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Nausea—Diltiazem—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Nausea—Indapamide—hypertension	2.41e-05	0.000122	CcSEcCtD
Frovatriptan—Hyperhidrosis—Ramipril—hypertension	2.4e-05	0.000121	CcSEcCtD
Frovatriptan—Asthenia—Trandolapril—hypertension	2.39e-05	0.000121	CcSEcCtD
Frovatriptan—Shock—Timolol—hypertension	2.39e-05	0.000121	CcSEcCtD
Frovatriptan—Feeling abnormal—Losartan—hypertension	2.39e-05	0.000121	CcSEcCtD
Frovatriptan—Nausea—Carvedilol—hypertension	2.38e-05	0.00012	CcSEcCtD
Frovatriptan—Asthenia—Enalapril—hypertension	2.38e-05	0.00012	CcSEcCtD
Frovatriptan—Abdominal pain—Furosemide—hypertension	2.37e-05	0.00012	CcSEcCtD
Frovatriptan—Body temperature increased—Furosemide—hypertension	2.37e-05	0.00012	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Losartan—hypertension	2.37e-05	0.00012	CcSEcCtD
Frovatriptan—Dizziness—Valsartan—hypertension	2.37e-05	0.00012	CcSEcCtD
Frovatriptan—Anorexia—Ramipril—hypertension	2.37e-05	0.00012	CcSEcCtD
Frovatriptan—Dizziness—Olmesartan—hypertension	2.36e-05	0.000119	CcSEcCtD
Frovatriptan—Pruritus—Trandolapril—hypertension	2.36e-05	0.000119	CcSEcCtD
Frovatriptan—Nausea—Doxazosin—hypertension	2.36e-05	0.000119	CcSEcCtD
Frovatriptan—Arthralgia—Lisinopril—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Myalgia—Lisinopril—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Chest pain—Lisinopril—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Body temperature increased—Betaxolol—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Hyperhidrosis—Timolol—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Asthenia—Telmisartan—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Pruritus—Enalapril—hypertension	2.35e-05	0.000119	CcSEcCtD
Frovatriptan—Anxiety—Lisinopril—hypertension	2.34e-05	0.000118	CcSEcCtD
Frovatriptan—Diarrhoea—Clonidine—hypertension	2.34e-05	0.000118	CcSEcCtD
Frovatriptan—Nausea—Fosinopril—hypertension	2.33e-05	0.000118	CcSEcCtD
Frovatriptan—Discomfort—Lisinopril—hypertension	2.32e-05	0.000117	CcSEcCtD
Frovatriptan—Anorexia—Timolol—hypertension	2.32e-05	0.000117	CcSEcCtD
Frovatriptan—Pruritus—Telmisartan—hypertension	2.32e-05	0.000117	CcSEcCtD
Frovatriptan—Nausea—Eplerenone—hypertension	2.31e-05	0.000117	CcSEcCtD
Frovatriptan—Dry mouth—Lisinopril—hypertension	2.3e-05	0.000116	CcSEcCtD
Frovatriptan—Nausea—Nifedipine—hypertension	2.3e-05	0.000116	CcSEcCtD
Frovatriptan—Body temperature increased—Losartan—hypertension	2.29e-05	0.000116	CcSEcCtD
Frovatriptan—Abdominal pain—Losartan—hypertension	2.29e-05	0.000116	CcSEcCtD
Frovatriptan—Nausea—Verapamil—hypertension	2.29e-05	0.000115	CcSEcCtD
Frovatriptan—Asthenia—Captopril—hypertension	2.28e-05	0.000115	CcSEcCtD
Frovatriptan—Diarrhoea—Trandolapril—hypertension	2.28e-05	0.000115	CcSEcCtD
Frovatriptan—Vomiting—Valsartan—hypertension	2.28e-05	0.000115	CcSEcCtD
Frovatriptan—Confusional state—Lisinopril—hypertension	2.27e-05	0.000115	CcSEcCtD
Frovatriptan—Diarrhoea—Enalapril—hypertension	2.27e-05	0.000115	CcSEcCtD
Frovatriptan—Hypersensitivity—Irbesartan—hypertension	2.27e-05	0.000115	CcSEcCtD
Frovatriptan—Vomiting—Olmesartan—hypertension	2.27e-05	0.000115	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Ramipril—hypertension	2.26e-05	0.000114	CcSEcCtD
Frovatriptan—Dizziness—Clonidine—hypertension	2.26e-05	0.000114	CcSEcCtD
Frovatriptan—Anaphylactic shock—Lisinopril—hypertension	2.25e-05	0.000114	CcSEcCtD
Frovatriptan—Pruritus—Captopril—hypertension	2.25e-05	0.000114	CcSEcCtD
Frovatriptan—Hypersensitivity—Hydrochlorothiazide—hypertension	2.25e-05	0.000114	CcSEcCtD
Frovatriptan—Insomnia—Ramipril—hypertension	2.25e-05	0.000114	CcSEcCtD
Frovatriptan—Headache—Valsartan—hypertension	2.25e-05	0.000113	CcSEcCtD
Frovatriptan—Diarrhoea—Telmisartan—hypertension	2.24e-05	0.000113	CcSEcCtD
Frovatriptan—Headache—Olmesartan—hypertension	2.23e-05	0.000113	CcSEcCtD
Frovatriptan—Paraesthesia—Ramipril—hypertension	2.23e-05	0.000113	CcSEcCtD
Frovatriptan—Shock—Lisinopril—hypertension	2.22e-05	0.000112	CcSEcCtD
Frovatriptan—Asthenia—Perindopril—hypertension	2.22e-05	0.000112	CcSEcCtD
Frovatriptan—Dyspnoea—Ramipril—hypertension	2.22e-05	0.000112	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Timolol—hypertension	2.21e-05	0.000112	CcSEcCtD
Frovatriptan—Hypersensitivity—Furosemide—hypertension	2.21e-05	0.000112	CcSEcCtD
Frovatriptan—Asthenia—Irbesartan—hypertension	2.21e-05	0.000112	CcSEcCtD
Frovatriptan—Somnolence—Ramipril—hypertension	2.21e-05	0.000112	CcSEcCtD
Frovatriptan—Dizziness—Trandolapril—hypertension	2.2e-05	0.000111	CcSEcCtD
Frovatriptan—Tachycardia—Lisinopril—hypertension	2.2e-05	0.000111	CcSEcCtD
Frovatriptan—Insomnia—Timolol—hypertension	2.2e-05	0.000111	CcSEcCtD
Frovatriptan—Dizziness—Enalapril—hypertension	2.19e-05	0.000111	CcSEcCtD
Frovatriptan—Asthenia—Hydrochlorothiazide—hypertension	2.19e-05	0.000111	CcSEcCtD
Frovatriptan—Hypersensitivity—Betaxolol—hypertension	2.19e-05	0.000111	CcSEcCtD
Frovatriptan—Dyspepsia—Ramipril—hypertension	2.19e-05	0.000111	CcSEcCtD
Frovatriptan—Pruritus—Perindopril—hypertension	2.19e-05	0.00011	CcSEcCtD
Frovatriptan—Paraesthesia—Timolol—hypertension	2.18e-05	0.00011	CcSEcCtD
Frovatriptan—Pruritus—Irbesartan—hypertension	2.18e-05	0.00011	CcSEcCtD
Frovatriptan—Hyperhidrosis—Lisinopril—hypertension	2.18e-05	0.00011	CcSEcCtD
Frovatriptan—Diarrhoea—Captopril—hypertension	2.18e-05	0.00011	CcSEcCtD
Frovatriptan—Vomiting—Clonidine—hypertension	2.17e-05	0.00011	CcSEcCtD
Frovatriptan—Dyspnoea—Timolol—hypertension	2.17e-05	0.000109	CcSEcCtD
Frovatriptan—Dizziness—Telmisartan—hypertension	2.16e-05	0.000109	CcSEcCtD
Frovatriptan—Pruritus—Hydrochlorothiazide—hypertension	2.16e-05	0.000109	CcSEcCtD
Frovatriptan—Decreased appetite—Ramipril—hypertension	2.16e-05	0.000109	CcSEcCtD
Frovatriptan—Somnolence—Timolol—hypertension	2.16e-05	0.000109	CcSEcCtD
Frovatriptan—Asthenia—Furosemide—hypertension	2.16e-05	0.000109	CcSEcCtD
Frovatriptan—Anorexia—Lisinopril—hypertension	2.15e-05	0.000109	CcSEcCtD
Frovatriptan—Fatigue—Ramipril—hypertension	2.14e-05	0.000108	CcSEcCtD
Frovatriptan—Headache—Clonidine—hypertension	2.14e-05	0.000108	CcSEcCtD
Frovatriptan—Dyspepsia—Timolol—hypertension	2.14e-05	0.000108	CcSEcCtD
Frovatriptan—Hypersensitivity—Losartan—hypertension	2.14e-05	0.000108	CcSEcCtD
Frovatriptan—Asthenia—Betaxolol—hypertension	2.13e-05	0.000108	CcSEcCtD
Frovatriptan—Nausea—Valsartan—hypertension	2.13e-05	0.000108	CcSEcCtD
Frovatriptan—Pruritus—Furosemide—hypertension	2.13e-05	0.000107	CcSEcCtD
Frovatriptan—Constipation—Ramipril—hypertension	2.13e-05	0.000107	CcSEcCtD
Frovatriptan—Nausea—Olmesartan—hypertension	2.12e-05	0.000107	CcSEcCtD
Frovatriptan—Vomiting—Trandolapril—hypertension	2.12e-05	0.000107	CcSEcCtD
Frovatriptan—Diarrhoea—Perindopril—hypertension	2.11e-05	0.000107	CcSEcCtD
Frovatriptan—Decreased appetite—Timolol—hypertension	2.11e-05	0.000107	CcSEcCtD
Frovatriptan—Vomiting—Enalapril—hypertension	2.11e-05	0.000107	CcSEcCtD
Frovatriptan—Diarrhoea—Irbesartan—hypertension	2.11e-05	0.000106	CcSEcCtD
Frovatriptan—Dizziness—Captopril—hypertension	2.1e-05	0.000106	CcSEcCtD
Frovatriptan—Pruritus—Betaxolol—hypertension	2.1e-05	0.000106	CcSEcCtD
Frovatriptan—Fatigue—Timolol—hypertension	2.09e-05	0.000106	CcSEcCtD
Frovatriptan—Diarrhoea—Hydrochlorothiazide—hypertension	2.09e-05	0.000106	CcSEcCtD
Frovatriptan—Headache—Trandolapril—hypertension	2.09e-05	0.000105	CcSEcCtD
Frovatriptan—Vomiting—Telmisartan—hypertension	2.08e-05	0.000105	CcSEcCtD
Frovatriptan—Asthenia—Losartan—hypertension	2.08e-05	0.000105	CcSEcCtD
Frovatriptan—Headache—Enalapril—hypertension	2.08e-05	0.000105	CcSEcCtD
Frovatriptan—Pain—Timolol—hypertension	2.08e-05	0.000105	CcSEcCtD
Frovatriptan—Diarrhoea—Furosemide—hypertension	2.06e-05	0.000104	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Lisinopril—hypertension	2.05e-05	0.000104	CcSEcCtD
Frovatriptan—Pruritus—Losartan—hypertension	2.05e-05	0.000104	CcSEcCtD
Frovatriptan—Headache—Telmisartan—hypertension	2.05e-05	0.000104	CcSEcCtD
Frovatriptan—Feeling abnormal—Ramipril—hypertension	2.05e-05	0.000103	CcSEcCtD
Frovatriptan—Dizziness—Perindopril—hypertension	2.04e-05	0.000103	CcSEcCtD
Frovatriptan—Insomnia—Lisinopril—hypertension	2.04e-05	0.000103	CcSEcCtD
Frovatriptan—Dizziness—Irbesartan—hypertension	2.04e-05	0.000103	CcSEcCtD
Frovatriptan—Diarrhoea—Betaxolol—hypertension	2.03e-05	0.000103	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Ramipril—hypertension	2.03e-05	0.000103	CcSEcCtD
Frovatriptan—Nausea—Clonidine—hypertension	2.03e-05	0.000103	CcSEcCtD
Frovatriptan—Paraesthesia—Lisinopril—hypertension	2.02e-05	0.000102	CcSEcCtD
Frovatriptan—Vomiting—Captopril—hypertension	2.02e-05	0.000102	CcSEcCtD
Frovatriptan—Dizziness—Hydrochlorothiazide—hypertension	2.02e-05	0.000102	CcSEcCtD
Frovatriptan—Dyspnoea—Lisinopril—hypertension	2.01e-05	0.000102	CcSEcCtD
Frovatriptan—Somnolence—Lisinopril—hypertension	2e-05	0.000101	CcSEcCtD
Frovatriptan—Feeling abnormal—Timolol—hypertension	2e-05	0.000101	CcSEcCtD
Frovatriptan—Headache—Captopril—hypertension	1.99e-05	0.000101	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Timolol—hypertension	1.99e-05	0.0001	CcSEcCtD
Frovatriptan—Dizziness—Furosemide—hypertension	1.99e-05	0.0001	CcSEcCtD
Frovatriptan—Dyspepsia—Lisinopril—hypertension	1.98e-05	0.0001	CcSEcCtD
Frovatriptan—Diarrhoea—Losartan—hypertension	1.98e-05	0.0001	CcSEcCtD
Frovatriptan—Nausea—Trandolapril—hypertension	1.98e-05	0.0001	CcSEcCtD
Frovatriptan—Nausea—Enalapril—hypertension	1.97e-05	9.96e-05	CcSEcCtD
Frovatriptan—Dizziness—Betaxolol—hypertension	1.97e-05	9.93e-05	CcSEcCtD
Frovatriptan—Vomiting—Perindopril—hypertension	1.96e-05	9.92e-05	CcSEcCtD
Frovatriptan—Body temperature increased—Ramipril—hypertension	1.96e-05	9.92e-05	CcSEcCtD
Frovatriptan—Abdominal pain—Ramipril—hypertension	1.96e-05	9.92e-05	CcSEcCtD
Frovatriptan—Decreased appetite—Lisinopril—hypertension	1.96e-05	9.9e-05	CcSEcCtD
Frovatriptan—Vomiting—Irbesartan—hypertension	1.96e-05	9.89e-05	CcSEcCtD
Frovatriptan—Nausea—Telmisartan—hypertension	1.94e-05	9.82e-05	CcSEcCtD
Frovatriptan—Fatigue—Lisinopril—hypertension	1.94e-05	9.82e-05	CcSEcCtD
Frovatriptan—Vomiting—Hydrochlorothiazide—hypertension	1.94e-05	9.81e-05	CcSEcCtD
Frovatriptan—Headache—Perindopril—hypertension	1.94e-05	9.78e-05	CcSEcCtD
Frovatriptan—Headache—Irbesartan—hypertension	1.93e-05	9.75e-05	CcSEcCtD
Frovatriptan—Pain—Lisinopril—hypertension	1.93e-05	9.74e-05	CcSEcCtD
Frovatriptan—Constipation—Lisinopril—hypertension	1.93e-05	9.74e-05	CcSEcCtD
Frovatriptan—Body temperature increased—Timolol—hypertension	1.92e-05	9.7e-05	CcSEcCtD
Frovatriptan—Abdominal pain—Timolol—hypertension	1.92e-05	9.7e-05	CcSEcCtD
Frovatriptan—Dizziness—Losartan—hypertension	1.92e-05	9.68e-05	CcSEcCtD
Frovatriptan—Headache—Hydrochlorothiazide—hypertension	1.91e-05	9.67e-05	CcSEcCtD
Frovatriptan—Vomiting—Furosemide—hypertension	1.91e-05	9.65e-05	CcSEcCtD
Frovatriptan—Vomiting—Betaxolol—hypertension	1.89e-05	9.55e-05	CcSEcCtD
Frovatriptan—Nausea—Captopril—hypertension	1.89e-05	9.55e-05	CcSEcCtD
Frovatriptan—Headache—Furosemide—hypertension	1.88e-05	9.51e-05	CcSEcCtD
Frovatriptan—Headache—Betaxolol—hypertension	1.86e-05	9.41e-05	CcSEcCtD
Frovatriptan—Feeling abnormal—Lisinopril—hypertension	1.86e-05	9.38e-05	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Lisinopril—hypertension	1.84e-05	9.31e-05	CcSEcCtD
Frovatriptan—Vomiting—Losartan—hypertension	1.84e-05	9.31e-05	CcSEcCtD
Frovatriptan—Nausea—Perindopril—hypertension	1.84e-05	9.27e-05	CcSEcCtD
Frovatriptan—Hypersensitivity—Ramipril—hypertension	1.83e-05	9.25e-05	CcSEcCtD
Frovatriptan—Nausea—Irbesartan—hypertension	1.83e-05	9.24e-05	CcSEcCtD
Frovatriptan—Headache—Losartan—hypertension	1.82e-05	9.17e-05	CcSEcCtD
Frovatriptan—Nausea—Hydrochlorothiazide—hypertension	1.81e-05	9.17e-05	CcSEcCtD
Frovatriptan—Hypersensitivity—Timolol—hypertension	1.79e-05	9.04e-05	CcSEcCtD
Frovatriptan—Nausea—Furosemide—hypertension	1.78e-05	9.01e-05	CcSEcCtD
Frovatriptan—Asthenia—Ramipril—hypertension	1.78e-05	9.01e-05	CcSEcCtD
Frovatriptan—Body temperature increased—Lisinopril—hypertension	1.78e-05	9e-05	CcSEcCtD
Frovatriptan—Abdominal pain—Lisinopril—hypertension	1.78e-05	9e-05	CcSEcCtD
Frovatriptan—Nausea—Betaxolol—hypertension	1.77e-05	8.92e-05	CcSEcCtD
Frovatriptan—Pruritus—Ramipril—hypertension	1.76e-05	8.88e-05	CcSEcCtD
Frovatriptan—Asthenia—Timolol—hypertension	1.74e-05	8.81e-05	CcSEcCtD
Frovatriptan—Nausea—Losartan—hypertension	1.72e-05	8.7e-05	CcSEcCtD
Frovatriptan—Pruritus—Timolol—hypertension	1.72e-05	8.68e-05	CcSEcCtD
Frovatriptan—Diarrhoea—Ramipril—hypertension	1.7e-05	8.59e-05	CcSEcCtD
Frovatriptan—Diarrhoea—Timolol—hypertension	1.66e-05	8.4e-05	CcSEcCtD
Frovatriptan—Hypersensitivity—Lisinopril—hypertension	1.66e-05	8.39e-05	CcSEcCtD
Frovatriptan—Dizziness—Ramipril—hypertension	1.64e-05	8.3e-05	CcSEcCtD
Frovatriptan—Asthenia—Lisinopril—hypertension	1.62e-05	8.17e-05	CcSEcCtD
Frovatriptan—Dizziness—Timolol—hypertension	1.61e-05	8.12e-05	CcSEcCtD
Frovatriptan—Pruritus—Lisinopril—hypertension	1.59e-05	8.06e-05	CcSEcCtD
Frovatriptan—Vomiting—Ramipril—hypertension	1.58e-05	7.98e-05	CcSEcCtD
Frovatriptan—Headache—Ramipril—hypertension	1.56e-05	7.86e-05	CcSEcCtD
Frovatriptan—Vomiting—Timolol—hypertension	1.54e-05	7.8e-05	CcSEcCtD
Frovatriptan—Diarrhoea—Lisinopril—hypertension	1.54e-05	7.79e-05	CcSEcCtD
Frovatriptan—Headache—Timolol—hypertension	1.52e-05	7.69e-05	CcSEcCtD
Frovatriptan—Dizziness—Lisinopril—hypertension	1.49e-05	7.53e-05	CcSEcCtD
Frovatriptan—Nausea—Ramipril—hypertension	1.48e-05	7.46e-05	CcSEcCtD
Frovatriptan—Nausea—Timolol—hypertension	1.44e-05	7.29e-05	CcSEcCtD
Frovatriptan—Vomiting—Lisinopril—hypertension	1.43e-05	7.24e-05	CcSEcCtD
Frovatriptan—Headache—Lisinopril—hypertension	1.41e-05	7.13e-05	CcSEcCtD
Frovatriptan—Nausea—Lisinopril—hypertension	1.34e-05	6.76e-05	CcSEcCtD
Frovatriptan—CYP1A2—Metabolism—FADS1—hypertension	5.7e-06	6.7e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RHOA—hypertension	5.7e-06	6.7e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—C3—hypertension	5.69e-06	6.69e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDGFB—hypertension	5.66e-06	6.65e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT2—hypertension	5.64e-06	6.63e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3R1—hypertension	5.64e-06	6.63e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGFR1—hypertension	5.63e-06	6.62e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—hypertension	5.61e-06	6.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—hypertension	5.55e-06	6.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TBXAS1—hypertension	5.54e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CA9—hypertension	5.54e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—hypertension	5.54e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDGFB—hypertension	5.54e-06	6.51e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—hypertension	5.52e-06	6.49e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGFR1—hypertension	5.51e-06	6.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCE—hypertension	5.48e-06	6.45e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—hypertension	5.47e-06	6.44e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CALM1—hypertension	5.43e-06	6.39e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—hypertension	5.43e-06	6.38e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	5.42e-06	6.37e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VAV3—hypertension	5.42e-06	6.37e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDGFA—hypertension	5.42e-06	6.37e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—hypertension	5.41e-06	6.36e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—hypertension	5.41e-06	6.36e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—hypertension	5.41e-06	6.36e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALOX5AP—hypertension	5.4e-06	6.35e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALOX15—hypertension	5.4e-06	6.35e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CAV1—hypertension	5.36e-06	6.3e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—hypertension	5.35e-06	6.29e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFBR2—hypertension	5.34e-06	6.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—hypertension	5.33e-06	6.27e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CALM1—hypertension	5.32e-06	6.25e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—hypertension	5.3e-06	6.23e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—hypertension	5.3e-06	6.23e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—hypertension	5.3e-06	6.23e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNB3—hypertension	5.29e-06	6.22e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HADHA—hypertension	5.27e-06	6.2e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LHB—hypertension	5.27e-06	6.2e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CAV1—hypertension	5.25e-06	6.17e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—hypertension	5.24e-06	6.16e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AVP—hypertension	5.22e-06	6.14e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—hypertension	5.19e-06	6.1e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RHOA—hypertension	5.17e-06	6.08e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPA—hypertension	5.15e-06	6.06e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—KCNJ11—hypertension	5.15e-06	6.06e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD3B2—hypertension	5.15e-06	6.06e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNAS—hypertension	5.15e-06	6.06e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3R1—hypertension	5.12e-06	6.02e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCB—hypertension	5.1e-06	6e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—F2—hypertension	5.1e-06	6e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FN1—hypertension	5.1e-06	6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOB—hypertension	5.04e-06	5.93e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTK2—hypertension	5.02e-06	5.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—hypertension	5e-06	5.88e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—F2—hypertension	5e-06	5.88e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FN1—hypertension	5e-06	5.88e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCB—hypertension	5e-06	5.88e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH1—hypertension	4.99e-06	5.87e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—hypertension	4.96e-06	5.84e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—hypertension	4.96e-06	5.83e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LRP2—hypertension	4.94e-06	5.81e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2C18—hypertension	4.94e-06	5.81e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—hypertension	4.92e-06	5.79e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH1—hypertension	4.89e-06	5.75e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—hypertension	4.82e-06	5.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—hypertension	4.8e-06	5.64e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—H2AFX—hypertension	4.78e-06	5.62e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDGFRB—hypertension	4.77e-06	5.61e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RPS6KB1—hypertension	4.77e-06	5.61e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSPG2—hypertension	4.76e-06	5.59e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADCY5—hypertension	4.71e-06	5.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—hypertension	4.7e-06	5.53e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCG—hypertension	4.68e-06	5.51e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—hypertension	4.66e-06	5.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCA—hypertension	4.65e-06	5.47e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ITGB3—hypertension	4.65e-06	5.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—hypertension	4.65e-06	5.47e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—hypertension	4.65e-06	5.47e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—hypertension	4.62e-06	5.44e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—YWHAZ—hypertension	4.61e-06	5.42e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLP1R—hypertension	4.59e-06	5.4e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALOX5—hypertension	4.59e-06	5.4e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGF—hypertension	4.56e-06	5.36e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SPP1—hypertension	4.56e-06	5.36e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—hypertension	4.55e-06	5.35e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—hypertension	4.55e-06	5.35e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—hypertension	4.54e-06	5.34e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—hypertension	4.53e-06	5.32e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—hypertension	4.47e-06	5.26e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT2—hypertension	4.47e-06	5.25e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—hypertension	4.45e-06	5.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—hypertension	4.45e-06	5.23e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—hypertension	4.44e-06	5.22e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCD—hypertension	4.44e-06	5.22e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—hypertension	4.38e-06	5.15e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT2—hypertension	4.38e-06	5.14e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—hypertension	4.36e-06	5.12e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—hypertension	4.34e-06	5.11e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—C3—hypertension	4.34e-06	5.1e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—hypertension	4.25e-06	4.99e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDGFB—hypertension	4.22e-06	4.96e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDH2—hypertension	4.2e-06	4.94e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGFR1—hypertension	4.2e-06	4.94e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—hypertension	4.16e-06	4.89e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—hypertension	4.13e-06	4.86e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—hypertension	4.12e-06	4.84e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF2—hypertension	4.11e-06	4.83e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—hypertension	4.1e-06	4.82e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RHOA—hypertension	4.1e-06	4.82e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HBA1—hypertension	4.09e-06	4.81e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP11A1—hypertension	4.07e-06	4.79e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3R1—hypertension	4.05e-06	4.77e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—hypertension	4.05e-06	4.77e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALM1—hypertension	4.05e-06	4.76e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypertension	4.04e-06	4.75e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—hypertension	4.04e-06	4.75e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—hypertension	4.04e-06	4.75e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF2—hypertension	4.02e-06	4.73e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RHOA—hypertension	4.01e-06	4.72e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CAV1—hypertension	4e-06	4.7e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—hypertension	4e-06	4.7e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC9A1—hypertension	4e-06	4.7e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—hypertension	3.99e-06	4.69e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3R1—hypertension	3.97e-06	4.67e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—hypertension	3.97e-06	4.67e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—hypertension	3.95e-06	4.65e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCLC—hypertension	3.95e-06	4.65e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CETP—hypertension	3.95e-06	4.65e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RELA—hypertension	3.82e-06	4.49e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—F2—hypertension	3.81e-06	4.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCB—hypertension	3.81e-06	4.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FN1—hypertension	3.81e-06	4.48e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP17A1—hypertension	3.78e-06	4.45e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO1—hypertension	3.74e-06	4.4e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS1—hypertension	3.74e-06	4.4e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTOR—hypertension	3.74e-06	4.4e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RELA—hypertension	3.74e-06	4.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH1—hypertension	3.72e-06	4.38e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	3.68e-06	4.33e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTOR—hypertension	3.66e-06	4.31e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CTGF—hypertension	3.6e-06	4.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—hypertension	3.6e-06	4.23e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMGCR—hypertension	3.57e-06	4.2e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT2—hypertension	3.57e-06	4.2e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	3.52e-06	4.14e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—hypertension	3.52e-06	4.14e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADRA2A—hypertension	3.5e-06	4.11e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—hypertension	3.47e-06	4.09e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—hypertension	3.47e-06	4.08e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—hypertension	3.45e-06	4.05e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—hypertension	3.42e-06	4.02e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—hypertension	3.4e-06	4e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—hypertension	3.39e-06	3.99e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—hypertension	3.35e-06	3.94e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—hypertension	3.34e-06	3.92e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT2—hypertension	3.33e-06	3.92e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—hypertension	3.32e-06	3.9e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TH—hypertension	3.27e-06	3.85e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CALM2—hypertension	3.26e-06	3.84e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—hypertension	3.25e-06	3.82e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1A—hypertension	3.24e-06	3.81e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTEN—hypertension	3.23e-06	3.8e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	3.22e-06	3.79e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—hypertension	3.18e-06	3.75e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCG—hypertension	3.18e-06	3.74e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A4—hypertension	3.18e-06	3.74e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1A—hypertension	3.17e-06	3.73e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—hypertension	3.17e-06	3.72e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTEN—hypertension	3.17e-06	3.72e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—hypertension	3.16e-06	3.72e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—hypertension	3.15e-06	3.71e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—hypertension	3.1e-06	3.64e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—hypertension	3.09e-06	3.63e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT1—hypertension	3.08e-06	3.63e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EP300—hypertension	3.08e-06	3.63e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF2—hypertension	3.07e-06	3.61e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RHOA—hypertension	3.06e-06	3.59e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3R1—hypertension	3.02e-06	3.56e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—hypertension	3.02e-06	3.56e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EP300—hypertension	3.02e-06	3.55e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—hypertension	3e-06	3.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STK11—hypertension	2.99e-06	3.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP19A1—hypertension	2.99e-06	3.52e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—hypertension	2.94e-06	3.45e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—hypertension	2.92e-06	3.43e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—hypertension	2.86e-06	3.36e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RELA—hypertension	2.85e-06	3.35e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.81e-06	3.3e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTOR—hypertension	2.79e-06	3.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COMT—hypertension	2.78e-06	3.27e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNB3—hypertension	2.74e-06	3.23e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1A—hypertension	2.74e-06	3.23e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—hypertension	2.73e-06	3.21e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAT—hypertension	2.7e-06	3.17e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—hypertension	2.69e-06	3.16e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—hypertension	2.68e-06	3.15e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—hypertension	2.68e-06	3.15e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	2.68e-06	3.15e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNAS—hypertension	2.67e-06	3.14e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—hypertension	2.63e-06	3.09e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—hypertension	2.63e-06	3.09e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—hypertension	2.62e-06	3.09e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOB—hypertension	2.62e-06	3.08e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—hypertension	2.59e-06	3.05e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—hypertension	2.57e-06	3.03e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—hypertension	2.55e-06	3e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—hypertension	2.55e-06	2.99e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—hypertension	2.5e-06	2.94e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADCY5—hypertension	2.45e-06	2.88e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—hypertension	2.44e-06	2.87e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—hypertension	2.43e-06	2.85e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1A—hypertension	2.42e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PRKCA—hypertension	2.41e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1A1—hypertension	2.41e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTEN—hypertension	2.41e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD36—hypertension	2.37e-06	2.79e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—hypertension	2.36e-06	2.77e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—hypertension	2.35e-06	2.77e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EP300—hypertension	2.3e-06	2.7e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—hypertension	2.25e-06	2.65e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—hypertension	2.24e-06	2.63e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARA—hypertension	2.21e-06	2.6e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—hypertension	2.21e-06	2.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—hypertension	2.18e-06	2.56e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—hypertension	2.16e-06	2.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—hypertension	2.14e-06	2.51e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CALM1—hypertension	2.1e-06	2.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—hypertension	2.09e-06	2.46e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAV1—hypertension	2.08e-06	2.44e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—hypertension	2.07e-06	2.43e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—hypertension	2.02e-06	2.38e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—hypertension	2e-06	2.36e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—hypertension	2e-06	2.35e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—hypertension	1.98e-06	2.33e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—hypertension	1.96e-06	2.31e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—hypertension	1.86e-06	2.19e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—hypertension	1.82e-06	2.15e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—hypertension	1.82e-06	2.15e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—hypertension	1.8e-06	2.12e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—hypertension	1.79e-06	2.1e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—hypertension	1.65e-06	1.94e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—hypertension	1.64e-06	1.93e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3R1—hypertension	1.57e-06	1.85e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—hypertension	1.57e-06	1.85e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—hypertension	1.51e-06	1.77e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—hypertension	1.44e-06	1.69e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—hypertension	1.39e-06	1.63e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTEN—hypertension	1.25e-06	1.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—EP300—hypertension	1.19e-06	1.4e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—hypertension	7.21e-07	8.48e-06	CbGpPWpGaD
